The score is weighed down primarily by weakening financial performance (margin compression, zero free cash flow in 2025, and elevated leverage) and very bearish technicals (below all major moving averages with negative MACD). Valuation is only modestly supportive due to the dividend yield, but the high P/E limits upside support.
Positive Factors
Large global retail and service network
Amplifon's multinational clinic network and integrated audiology services create durable distribution and recurring revenue streams. The bundled model (assessments, fitting, after-sales) supports customer retention, repeat service revenue and operational scale advantages that persist beyond short-term cycles.
Negative Factors
Revenue decline and net margin compression (2025)
A 2025 revenue dip and sharp net margin decline to ~3.8% signal weakening profitability and demand conversion. Persistent revenue and margin pressure reduces sustainable cash flow and return on capital, challenging the company's ability to fund growth or rebalance its capital structure without operational improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Large global retail and service network
Amplifon's multinational clinic network and integrated audiology services create durable distribution and recurring revenue streams. The bundled model (assessments, fitting, after-sales) supports customer retention, repeat service revenue and operational scale advantages that persist beyond short-term cycles.
Read all positive factors
Amplifon S.p.A. (AMP) vs. iShares MSCI Italy ETF (EWI)
Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized pr...
Read more
How the Company Makes Money
Amplifon primarily makes money through retail hearing-care operations. Its main revenue stream is the sale of hearing aids and related devices (typically bundled with professional services such as hearing tests, fitting, and fine-tuning). A signif...
Read more
Amplifon S.p.A. Financial Statement Overview
Summary
Financials show late-cycle pressure: 2025 revenue dipped slightly, net margin fell sharply versus prior years, and free cash flow dropped to zero. Leverage remains elevated (~1.4–1.5x debt/equity), reducing flexibility while profitability and cash conversion weaken.
Income Statement
56
Neutral
Balance Sheet
49
Neutral
Cash Flow
45
Neutral
Breakdown
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
2.40B
2.41B
2.26B
2.12B
1.95B
Gross Profit
199.02M
1.36B
548.45M
1.18B
1.11B
EBITDA
514.10M
557.25M
522.01M
513.82M
468.72M
Net Income
91.33M
145.37M
155.14M
178.53M
157.78M
Balance Sheet
Total Assets
3.57B
3.99B
3.69B
3.58B
3.52B
Cash, Cash Equivalents and Short-Term Investments
308.88M
288.85M
194.00M
229.54M
318.44M
Total Debt
1.53B
1.72B
1.52B
1.50B
1.61B
Total Liabilities
2.57B
2.84B
2.59B
2.54B
2.59B
Stockholders Equity
998.21M
1.15B
1.10B
1.04B
925.18M
Cash Flow
Free Cash Flow
0.00
366.19M
271.89M
342.99M
348.97M
Operating Cash Flow
274.85M
449.35M
413.54M
458.62M
462.37M
Investing Cash Flow
-178.97M
-335.10M
-261.48M
-193.78M
-533.61M
Financing Cash Flow
-172.65M
-18.85M
-135.06M
-353.80M
-208.64M
Amplifon S.p.A. Technical Analysis
Technical Analysis Sentiment
Negative
Last Price9.20
Price Trends
50DMA
11.36
Negative
100DMA
12.46
Negative
200DMA
14.34
Negative
Market Momentum
MACD
-0.56
Negative
RSI
38.24
Neutral
STOCH
61.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Negative. The current price of 9.2 is above the 20-day moving average (MA) of 9.02, below the 50-day MA of 11.36, and below the 200-day MA of 14.34, indicating a neutral trend. The MACD of -0.56 indicates Negative momentum. The RSI at 38.24 is Neutral, neither overbought nor oversold. The STOCH value of 61.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:AMP.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 18, 2026